NCT04970056 2026-04-22
PRECEDE
Arbor Research Collaborative for Health
Recruiting
Clinical Trials
2,444 trialsNCT06423326 2026-04-22
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
Emory University
Phase 2 Recruiting
NCT06893276 2026-04-22
e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients
University of Miami
Phase NA Not yet recruiting
NCT01692873 2026-04-21
PACAomics
Institut Paoli-Calmettes
Phase NA Completed
NCT03919292 2026-04-21
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
Virginia Commonwealth University
Phase 1/2 Recruiting
NCT04544046 2026-04-21
Supportive Oncology Care At Home RCT
Massachusetts General Hospital
Phase NA Active not recruiting
NCT07542782 2026-04-21
PRONPaC
Medizinische Hochschule Brandenburg Theodor Fontane
Completed
NCT04128332 2026-04-20
PORTICO-SABR
Cambridge University Hospitals NHS Foundation Trust
Phase NA Completed
NCT05632328 2026-04-20
AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC
Beth Israel Deaconess Medical Center
Phase 2 Active not recruiting
NCT06705335 2026-04-20
CONVERCAP
Institut Bergonié
Recruiting
NCT07539155 2026-04-20
Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer
University of Arkansas
Phase 1/2 Not yet recruiting
NCT04158635 2026-04-17
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
City of Hope Medical Center
Phase 1 Recruiting
NCT04387071 2026-04-17
CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma
University of Southern California
Phase 1/2 Terminated
NCT04899739 2026-04-17
EchoSurg
IHU Strasbourg
Phase NA Completed
NCT07536841 2026-04-17
ОС26
Military Medical Clinical Center of the Southern Region, Ukraine
Not yet recruiting
NCT04940286 2026-04-16
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05497778 2026-04-16
A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT03168737 2026-04-15
18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT03682289 2026-04-15
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
Phase 2 Recruiting
NCT04837118 2026-04-15
Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT05065801 2026-04-15
GABRINOX2
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Recruiting
NCT05247164 2026-04-15
EUPhORIC
IRCCS San Raffaele
Phase NA Completed
NCT05394259 2026-04-15
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT05692323 2026-04-15
PREHAB
Cedars-Sinai Medical Center
Phase NA Active not recruiting
NCT06593431 2026-04-15
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT07126158 2026-04-15
Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
Washington University School of Medicine
Phase 2 Recruiting
NCT07353645 2026-04-15
KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2 Recruiting
NCT07360119 2026-04-15
Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Not yet recruiting
NCT07458347 2026-04-15
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
Phase 1 Recruiting
NCT07513116 2026-04-14
Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening
M.D. Anderson Cancer Center
Phase NA Not yet recruiting
NCT07528430 2026-04-14
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
University of Maryland, Baltimore
Not yet recruiting
NCT07529626 2026-04-14
MIND-PANC
Shanghai Zhongshan Hospital
Not yet recruiting
NCT02872831 2026-04-13
Beacon BNXâ„¢ Endoscopic Ultrasound (EUS)-Needle vs SharkCoreâ„¢ Needle
Thomas Jefferson University
Phase NA Withdrawn
NCT03250078 2026-04-13
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
Nuvance Health
Recruiting
NCT03403049 2026-04-13
Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
Montefiore Medical Center
Phase 1 Completed
NCT03937453 2026-04-13
PANDOME
Nuvance Health
Recruiting
NCT04406831 2026-04-13
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
Nuvance Health
Recruiting
NCT06454383 2026-04-13
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
City of Hope Medical Center
Phase 1 Recruiting
NCT07494994 2026-04-13
SURGIMEDIA
UNC Lineberger Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT06958328 2026-04-08
LAP100
NRG Oncology
Phase 3 Recruiting
NCT07516392 2026-04-08
PRE-PDAC
Catholic University of the Sacred Heart
Phase NA Not yet recruiting
NCT04449406 2026-04-07
UroPanc
Queen Mary University of London
Active not recruiting
NCT05743049 2026-04-07
Collection of Circulating Biomarkers in Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Recruiting
NCT06639724 2026-04-07
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
University of California, San Diego
Phase 1 Recruiting
NCT04132505 2026-04-06
Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT07478185 2026-04-03
Prehab for Pancreatic Cancer Surgery
University of Massachusetts, Worcester
Phase NA Recruiting
NCT01102556 2026-04-02
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
Columbia University
Recruiting
NCT04820179 2026-04-02
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer
University of Arizona
Phase 2 Active not recruiting
NCT05617872 2026-04-02
Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound
Peking Union Medical College Hospital
Phase NA Completed
NCT01580241 2026-04-01
Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer
University of Oklahoma
Active not recruiting